NUTX
Nutex Health, Inc.NASDAQHealthcare$100.92+2.52%ClosedMarket Cap: $600.9M
As of 2026-04-06
Valuation
P/E (TTM)
9.36
PEG
0.41
P/B
2.05
P/S
0.69
EV/EBITDA
2.75
DCF Value
$-500.60
FCF Yield
40.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
50.8%
Operating Margin
30.5%
Net Margin
7.3%
ROE
23.8%
ROA
7.3%
ROIC
25.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $151.7M | 30.4% | $30.9M | $11.8M | $1.62 | — |
| FY 2025 | $875.3M | 50.8% | $275.6M | $70.8M | $10.48 | — |
| Q3 2025 | $267.8M | 57.8% | $130.4M | $55.4M | $7.76 | — |
| Q2 2025 | $244.0M | 51.2% | $33.7M | $-17.7M | $-3.02 | — |
| Q1 2025 | $211.8M | 55.9% | $72.2M | $14.6M | $2.56 | — |
| Q4 2024 | $257.6M | 55.0% | $114.2M | $61.7M | $11.12 | — |
| FY 2024 | $479.9M | 40.9% | $130.6M | $52.2M | $9.71 | — |
| Q3 2024 | $78.8M | 27.8% | $9.7M | $-8.8M | $-1.72 | — |
| Q2 2024 | $76.1M | 29.7% | $5.3M | $-364.0K | $-0.07 | — |
| Q1 2024 | $67.5M | 15.1% | $1.4M | $-364.1K | $-0.08 | — |
| Q4 2023 | $69.7M | 19.0% | $-26.1M | $-31.6M | $-7.50 | — |
| FY 2023 | $247.6M | 14.0% | $-31.8M | $-45.8M | $-10.39 | — |